Massively parallel in vivo Perturb-seq reveals cell-type-specific transcriptional networks in cortical development

Xinhe Zheng,Boli Wu,Yuejia Liu,Sean K. Simmons,Kwanho Kim,Grace S. Clarke,Abdullah Ashiq,Joshua Park,Jiwen Li,Zhilin Wang,Liqi Tong,Qizhao Wang,Keerthi T. Rajamani,Rodrigo Muñoz-Castañeda,Shang Mu,Tianbo Qi,Yunxiao Zhang,Zi Chao Ngiam,Naoto Ohte,Carina Hanashima,Zhuhao Wu,Xiangmin Xu,Joshua Z. Levin,Xin Jin

DOI: https://doi.org/10.1016/j.cell.2024.04.050

2024-05-23

Cell Journal

Abstract:Highlights • Fast-onset AAVs reach high expression within two days in vivo • Transposon enhances expression and perturbation in brain and peripheral nervous systems • Cell-type-restricted effects of Foxg1 , whose perturbation leads to hybrid cell states • Modular platform for in vivo phenotypic CRISPR screen with scale Summary Leveraging AAVs' versatile tropism and labeling capacity, we expanded the scale of in vivo CRISPR screening with single-cell transcriptomic phenotyping across embryonic to adult brains and peripheral nervous systems. Through extensive tests of 86 vectors across AAV serotypes combined with a transposon system, we substantially amplified labeling efficacy and accelerated in vivo gene delivery from weeks to days. Our proof-of-principle in utero screen identified the pleiotropic effects of Foxg1 , highlighting its tight regulation of distinct networks essential for cell fate specification of Layer 6 corticothalamic neurons. Notably, our platform can label >6% of cerebral cells, surpassing the current state-of-the-art efficacy at <0.1% by lentivirus, to achieve analysis of over 30,000 cells in one experiment and enable massively parallel in vivo Perturb-seq. Compatible with various phenotypic measurements (single-cell or spatial multi-omics), it presents a flexible approach to interrogate gene function across cell types in vivo , translating gene variants to their causal function. Graphical abstract Download : Download high-res image (170KB) Download : Download full-size image

cell biology